Issue : The Pharmaceutical Journal, May 2020, Vol 304, No 7937
Sort by: Newest first Oldest first A-Z Z-A
-
Apixaban may be more effective and safer than rivaroxaban, research suggests Subscription
Adults with non-valvular atrial fibrillation prescribed apixaban have a lower rate of ischaemic stroke and systemic blood clots compared with those prescribed rivaroxaban, according to a retrospective cohort study in Annals of Internal Medicine.
-
'As I listen, I form an action plan' — a day in the life of a patient support officer Subscription
When her son fell chronically ill, Arlene Brailey found the motivation to take on a role dedicated to helping patients with resistant bacterial infections find support and trustworthy information.
-
Buprenorphine implant beneficial for patients with opioid dependency Subscription
The benefits of delivering buprenorphine by subcutaneous implant, rather than by sublingual tablet, for the treatment of opioid dependence outweigh the risks, research published in BMJ Evidence Based Medicine sugggests
-
Care home pharmacists redeployed, despite COVID-19 palliative care increase
Exclusive: Pharmacy staff in care homes are being redeployed to cover other roles during the COVID-19 pandemic, even though demands on care homes are increasing rapidly, The Pharmaceutical Journal has learnt.
-
Case-based learning: anxiety disorders Subscription
There are many types of anxiety disorders with varying levels of severity. Pharmacists should know the treatment options that are available and how to support patients.
-
Community management of pneumonia and suspected COVID-19
The COVID-19 pandemic has highlighted the importance of understanding the differences between viral and bacterial pneumonia, and how adult patients can be managed as they recover at home.
-
Community pharmacies need £200m extra to stay afloat during COVID-19, trade body warns
Community pharmacies need millions of pounds extra “to keep their heads above water” during the COVID-19 pandemic, pharmacy bodies have warned.
-
Community pharmacists will now be included in COVID-19 death-in-service scheme
Community pharmacists are to be included in the government life assurance scheme for staff working on the frontline of the COVID-19 pandemic, the health secretary, Matt Hancock has announced.
-
Deaths: David Wood
On 12 April 2020, David Wood MRPharmS, aged 66 years, of Lanarkshire, Scotland. Dr Wood registered with the Society in 1976.
-
Deaths: Ernest Oldcorn
On 14 April 2020, Ernest Oldcorn, aged 96 years, of Virginia Water, Surrey. Mr Oldcorn registered with the Society in 1945 and left in 1988.
Show 10 per page20 per page50 per page
